![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Martínez-Montemayor Michelle Otero-Franqui Elisa Martinez Joel De La Mota-Peynado Alina Cubano Luis Dharmawardhane Suranganie
Publisher: Springer Publishing Company
ISSN: 0262-0898
Source: Clinical and Experimental Metastasis, Vol.27, Iss.7, 2010-10, pp. : 465-480
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prolonged time to progression with fulvestrant for metastatic breast cancer
By Mello Celso
Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. :